1. Levels of protein C and soluble thrombomodulin in critically ill patients with acute kidney injury: a multicenter prospective observational study.

    PLoS ONE 10(3):e0120770 (2015) PMID 25790110 PMCID PMC4366245

    Endothelial dysfunction contributes to the development of acute kidney injury (AKI) in animal models of ischemia reperfusion injury and sepsis. There are limited data on markers of endothelial dysfunction in human AKI. We hypothesized that Protein C (PC) and soluble thrombomodulin (sTM) levels c...
  2. Soluble thrombomodulin reduces inflammation and prevents microalbuminuria induced by chronic endothelial activation in transgenic mice.

    American Journal of Physiology: Renal, Fluid & ... 302(6):F703 (2012) PMID 22129968 PMCID PMC3311320

    Chronic kidney disease pathogenesis involves both tubular and vascular injuries. Despite abundant investigations to identify the risk factors, the involvement of chronic endothelial dysfunction in developing nephropathies is insufficiently explored. Previously, soluble thrombomodulin (sTM), a co...
  3. Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes.

    Blood 119(3):874 (2012) PMID 22117049 PMCID PMC3398751

    The cytoprotective effects of activated protein C (aPC) are well established. In contrast, the receptors and signaling mechanism through which aPC conveys cytoprotection in various cell types remain incompletely defined. Thus, within the renal glomeruli, aPC preserves endothelial cells via a pro...
  4. Recombinant activated protein C attenuates coagulopathy and inflammation when administered early in murine pneumococcal pneumonia.

    Thrombosis and Haemostasis 106(6):1189 (2011) PMID 21901240

    Recombinant human activated protein C (APC), which has both anticoagulant and anti-inflammatory properties, improves survival of patients with severe sepsis. This beneficial effect is especially apparent in patients with pneumococcal pneumonia. Earlier treatment with APC in sepsis has been assoc...
  5. Therapeutic recombinant murine activated protein C attenuates pulmonary coagulopathy and improves survival in murine pneumococcal pneumonia.

    Journal of Infectious Diseases 202(10):1600 (2010) PMID 20925531

    Recombinant human activated protein C (APC) improves survival of patients with severe sepsis; this beneficial effect is especially apparent in patients with pneumococcal pneumonia. The aim of this study was to determine the effect of APC treatment initiated after induction of pneumococcal pneumo...
  6. Activated protein C ameliorates coagulopathy but does not influence outcome in lethal H1N1 influenza: a controlled laboratory study.

    Critical care (London, England) 14(2):R65 (2010) PMID 20398279 PMCID PMC2887187

    Influenza accounts for 5 to 10% of community-acquired pneumonias and is a major cause of mortality. Sterile and bacterial lung injuries are associated with procoagulant and inflammatory derangements in the lungs. Activated protein C (APC) is an anticoagulant with anti-inflammatory properties tha...
  7. Activated protein C and acute kidney injury: Selective targeting of PAR-1.

    Current Drug Targets 10(12):1212 (2009) PMID 19715537

    Protein C is a plasma serine protease that when activated plays a central role in modulating the function of the vascular endothelium and its interface with the innate immune system. Activated protein C (APC) has a dual mechanism of action via the feedback inhibition of thrombin generation, and ...
  8. Soluble thrombomodulin protects ischemic kidneys.

    Journal of the American Society of Nephrology 20(3):524 (2009) PMID 19176699 PMCID PMC2653675

    Altered coagulation and inflammation contribute to the pathogenesis of ischemic renal injury. Thrombomodulin is a necessary factor in the anticoagulant protein C pathway and has inherent anti-inflammatory properties. We studied the effect of soluble thrombomodulin (sTM) in a hypoperfusion model ...
  9. Distinct functions of activated protein C differentially attenuate acute kidney injury.

    Journal of the American Society of Nephrology 20(2):267 (2009) PMID 19092124 PMCID PMC2637057

    Administration of activated protein C (APC) protects from renal dysfunction, but the underlying mechanism is unknown. APC exerts both antithrombotic and cytoprotective properties, the latter via modulation of protease-activated receptor-1 (PAR-1) signaling. We generated APC variants to study the...
  10. Treatment of sepsis-induced acquired protein C deficiency reverses Angiotensin-converting enzyme-2 inhibition and decreases pulmonary inflammatory response.

    Journal of Pharmacology and Experimental Therap... 325(1):17 (2008) PMID 18182560

    The protein C (PC) pathway plays an important role in vascular and immune function, and acquired deficiency during sepsis is associated with increased mortality in both animal models and in clinical studies. However, the association of acquired PC deficiency with the pathophysiology of lung inju...
  11. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.

    Nature 451(7182):1076 (2008) PMID 18278032

    Understanding the neuropathology of multiple sclerosis (MS) is essential for improved therapies. Therefore, identification of targets specific to pathological types of MS may have therapeutic benefits. Here we identify, by laser-capture microdissection and proteomics, proteins unique to three ma...
  12. Activated protein C modulates chemokine response and tissue injury in experimental sepsis.

    Advances in Experimental Medicine and Biology 614:83 (2008) PMID 18290317

    The protein C (PC) pathway plays an important role in vascular function, and acquired deficiency during sepsis is associated with increased mortality. We have explored the role of PC suppression in modulating early inflammatory events in a model of polymicrobial sepsis. We show that increased le...
  13. Negative regulation of inducible nitric-oxide synthase expression mediated through transforming growth factor-beta-dependent modulation of transcription factor TCF11.

    Journal of Biological Chemistry 282(51):36837 (2007) PMID 17928287

    Inducible nitric-oxide synthase (iNOS) plays a central role in the regulation of vascular function and response to injury. A central mediator controlling iNOS expression is transforming growth factor-beta (TGF-beta), which represses its expression through a mechanism that is poorly understood. W...
    PDF not found
  14. Activated protein C decreases tumor necrosis factor related apoptosis-inducing ligand by an EPCR- independent mechanism involving Egr-1/Erk-1/2 activation.

    Arteriosclerosis, Thrombosis, and Vascular Biology 27(12):2634 (2007) PMID 17932312

    Background- APC is an antithrombotic and antiinflammatory serine protease that plays an important role in vascular function. We report that APC can suppress the proapoptotic mediator TRAIL in human umbilical vein endothelial cells, and we have investigated the signaling mechanism. APC inhibited ...
  15. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis.

    Nature Medicine 13(11):1349 (2007) PMID 17982464

    Data providing direct evidence for a causative link between endothelial dysfunction, microvascular disease and diabetic end-organ damage are scarce. Here we show that activated protein C (APC) formation, which is regulated by endothelial thrombomodulin, is reduced in diabetic mice and causally l...
  16. Polymeric coatings that mimic the endothelium: combining nitric oxide release with surface-bound active thrombomodulin and heparin.

    Biomaterials 28(28):4047 (2007) PMID 17597201 PMCID PMC1986713

    Multi-functional bilayer polymeric coatings are prepared with both controlled nitric oxide (NO) release and surface-bound active thrombomodulin (TM) alone or in combination with immobilized heparin. The outer-layer is made of CarboSil, a commercially available copolymer of silicone rubber (SR) a...
  17. Activated protein C suppresses adrenomedullin and ameliorates lipopolysaccharide-induced hypotension.

    Shock 28(4):468 (2007) PMID 17558353

    Activated protein C (APC) is an important modulator of vascular function that has antithrombotic and anti-inflammatory properties. Studies in humans have shown modulation of endotoxin-induced hypotension by recombinant human APC, drotrecogin alfa (activated), however, the mechanism for this effe...
  18. Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2.

    American Journal of Physiology - Renal Physiology 293(1):F245 (2007) PMID 17409278

    Endothelial dysfunction contributes significantly to acute renal failure (ARF) during inflammatory diseases including septic shock. Previous studies have shown that activated protein C (APC) exhibits anti-inflammatory properties and modulates endothelial function. Therefore, we investigated the ...
  19. Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease.

    Journal of Clinical Investigation 117(7):1951 (2007) PMID 17557119 PMCID PMC1884689

    Endothelial protein C receptor (EPCR) and thrombomodulin (TM) are expressed at high levels in the resting microvasculature and convert protein C (PC) into its activated form, which is a potent anticoagulant and antiinflammatory molecule. Here we provide evidence that in Crohn disease (CD) and ul...
  20. Role of protein C in renal dysfunction after polymicrobial sepsis.

    Journal of the American Society of Nephrology 18(3):860 (2007) PMID 17301189

    Protein C (PC) plays an important role in vascular function, and acquired deficiency during sepsis is associated with increased mortality in both animal models and in clinical studies. This study explored the consequences of PC suppression on the kidney in a cecal ligation and puncture model of ...